Skip to content
Politically.com Search all
Menu

2025 · 1st Quarter (Jan 1 - Mar 31)

RARE DISEASE COMPANY COALITION

Filed by RARE DISEASE COMPANY COALITION.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Amendment
Posted
Apr 21, 2025
Income
Not reported
Expenses
$60,000.00
Filing UUID
ef4a4bfb-3542-428a-841d-0423ee4687c1
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

HR 4758 - Accelerating Kids Access to Care Act

Literal federal measure citations: HR 4758

PHA · Pharmacy

HR 1262 - Give Kids a Chance Act of 2025 S 932 - Give Kids a Chance Act of 2025 HR 946 - ORPHAN Cures Act S 3131 - ORPHAN Cures Act Technical Correction to IRA Orphan Exception HR 1414 - Camerons Law Orphan Drug Tax Credit HR 7384 - Creating Hope Reauthorization Act of 2024 S 4583 - Creating Hope Reauthorization Act of 2024

Literal federal measure citations: HR 1262, S 932, HR 946, S 3131, HR 1414, HR 7384, S 4583

SCI · Science/Technology

HR 1532 - Scientific EXPERT Act of 2025 S 822 - Scientific EXPERT Act of 2025

Literal federal measure citations: HR 1532, S 822

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.